Prognostic impact of specific IGHV rearrangements in younger untreated Mantle Cell Lymphoma patients is independent of p53 alterations and may be modified by ibrutinib-based regimens: Insights from the TRIANGLE trial within the MULTIPLY projectSimone Ragaini, Simone Ferrero, Elisa Genuardi et al.|Blood|2025Cited by 1
PS1274 EPIDEMIOLOGY AND MANAGEMENT OF LATENT TUBERCULOSIS INFECTION IN ADULT PATIENTS WITH ACUTE LEUKEMIA OR APLASTIC ANEMIA: A RETROSPECTIVE MONOCENTER STUDYFrancesca Bettelli, Fabio Forghieri, Davide Giusti et al.|HemaSphere|2019Cited by 0